The SARS-CoV-2 as an instrumental trigger of autoimmunity

A Dotan, S Muller, D Kanduc, P David, G Halpert… - Autoimmunity …, 2021 - Elsevier
Autoimmunity may be generated by a variety of factors by creating a hyper-stimulated state
of the immune system. It had been established long ago that viruses are a substantial …

The prevalence of olfactory and gustatory dysfunction in COVID-19 patients: a systematic review and meta-analysis

JY Tong, A Wong, D Zhu… - … –Head and Neck …, 2020 - journals.sagepub.com
Objective To determine the pooled global prevalence of olfactory and gustatory dysfunction
in patients with the 2019 novel coronavirus (COVID-19). Data Sources Literature searches of …

Anosmia in COVID-19: underlying mechanisms and assessment of an olfactory route to brain infection

R Butowt, CS von Bartheld - The Neuroscientist, 2021 - journals.sagepub.com
In recent months it has emerged that the novel coronavirus—responsible for the COVID-19
pandemic—causes reduction of smell and taste in a large fraction of patients. The …

Smell and taste dysfunction in patients with COVID-19: a systematic review and meta-analysis

AA Agyeman, KL Chin, CB Landersdorfer, D Liew… - Mayo Clinic …, 2020 - Elsevier
Objective To estimate the prevalence of olfactory and gustatory dysfunctions (OGDs) among
patients infected with novel coronavirus disease 2019 (COVID-19). Methods A systematic …

Body localization of ACE-2: on the trail of the keyhole of SARS-CoV-2

F Salamanna, M Maglio, MP Landini, M Fini - Frontiers in medicine, 2020 - frontiersin.org
The explosion of the new coronavirus (SARS-CoV-2) pandemic has brought the role of the
angiotensin converting enzyme 2 (ACE2) back into the scientific limelight. Since SARS-CoV …

More than smell—COVID-19 is associated with severe impairment of smell, taste, and chemesthesis

V Parma, K Ohla, MG Veldhuizen, MY Niv… - Chemical …, 2020 - academic.oup.com
Recent anecdotal and scientific reports have provided evidence of a link between COVID-19
and chemosensory impairments, such as anosmia. However, these reports have …

COVID-19: specific and non-specific clinical manifestations and symptoms: the current state of knowledge

J Baj, H Karakuła-Juchnowicz, G Teresiński… - Journal of clinical …, 2020 - mdpi.com
Coronavirus disease 2019 (COVID-19), due to the severe acute respiratory syndrome
coronavirus-2 (SARS-CoV-2), has become an epidemiological threat and a worldwide …

Prevalence and 6‐month recovery of olfactory dysfunction: a multicentre study of 1363 COVID‐19 patients

JR Lechien, CM Chiesa‐Estomba… - Journal of internal …, 2021 - Wiley Online Library
Objective To investigate prevalence and recovery of olfactory dysfunction (OD) in COVID‐19
patients according to the disease severity. Methods From 22 March to 3 June 2020, 2581 …

Neurological manifestations of COVID-19: a systematic review and meta-analysis of proportions

TT Favas, P Dev, RN Chaurasia, K Chakravarty… - Neurological …, 2020 - Springer
Background Coronaviruses mainly affect the respiratory system; however, there are reports
of SARS-CoV and MERS-CoV causing neurological manifestations. We aimed at discussing …

Neurological and neuropsychiatric impacts of COVID-19 pandemic

D Roy, R Ghosh, S Dubey, MJ Dubey… - Canadian Journal of …, 2021 - cambridge.org
Background: Albeit primarily a disease of respiratory tract, the 2019 coronavirus infectious
disease (COVID-19) has been found to have causal association with a plethora of …